TITLE

Pragmatic randomised controlled trial of preferred intensity exercise in women living with depression

AUTHOR(S)
Callaghan, Patrick; Khalil, Elizabeth; Morres, Ioannis; Carter, Tim
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p465
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Exercise may be effective in treating depression, but trials testing its effect in depressed women are rare. Aim: To compare the effect of exercise of preferred intensity with exercise of prescribed intensity in thirty-eight women living with depression. Methods: A Pragmatic RCT of 12 sessions of exercise at preferred intensity compared with 12 sessions at prescribed intensity. Beck Depression Inventory (BDI), Rosenberg Self Esteem Scale (RSES), General Health Questionnaire 12 (GHQ-12), heart rate (HR), Rating of Perceived Exertion Scale (RPE), Quality of Life in Depression Scale (QLDS), Multi-Dimensional Scale of Perceived Social Support (MDSPSS), SF12 Health Survey and exercise participation rates were compared between groups. Results: Intervention participants had statistically better BDI (t = 2.638, df = 36, p = 0.006, 95% mean (SD) 26.5 (10.7), CI-20.4 to -2.7, d = 0.86), GHQ-12 (t = 3.284, df = 36, p = 0.001, mean (SD) 8.3 (3.7) 95% CI -6.5 to -1.5, d = 1.08), RSES (t = 2.045, df = 36, p = 0.024, mean (SD) 11.3 (5.8), 95% CI 0.3 -6.4, d = 0.25), QLDS (t = 1.902, df = 36, p = 0.0325, mean (SD) 15.5 (7.9), 95% CI -12.2 -0.4, d = 0.27) RPE scores (t = 1.755, df = 36, p = 0.0475, mean (SD) 9.2 (3.2), 95% CI -.5 - 5.2, d = 0.77) and attended more exercise sessions (t = 1.781, df = 36, p = 0.0415, number of sessions 8 (65%), 95% CI-0.3 -4.8, d = 0.58). SF-12, MSPSS and HR did not differ significantly between groups. Conclusions: Exercise of preferred intensity improves psychological, physiological and social outcomes, and exercise participation rates in women living with depression.
ACCESSION #
62668348

 

Related Articles

  • An analysis of correlations among four outcome scales employed in clinical trials of patients with major depressive disorder. Qin Jiang; Ahmed, Saeeduddin // Annals of General Psychiatry;2009, Vol. 8, Special section p1 

    Background: The 17-item Hamilton Depression Rating Scale (HAM-D17) remains the 'gold standard' for measuring treatment outcomes in clinical trials of depressed patients. The Montgomery sberg Depression Rating Scale (MADRS), Clinical Global Impressions-Severity (CGIS) and -Improvement (CGI-I)...

  • The Potential Biomarker Panels for Identification of Major Depressive Disorder (MDD) Patients with and without Early Life Stress (ELS) by Metabonomic Analysis. Ding, Xinghua; Yang, Shuguang; Li, Wuju; Liu, Yong; Li, Zhiguo; Zhang, Yan; Li, Lingjiang; Liu, Shaojun // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Objective: The lack of the disease biomarker to support objective laboratory tests still constitutes a bottleneck in the clinical diagnosis and evaluation of major depressive disorder (MDD) and its subtypes. We used metabonomic techniques to screen the diagnostic biomarker panels from the plasma...

  • Evaluation of Mood Disorder Questionnaire (MDQ) in Patients with Mood Disorders: A Multicenter Trial across China. Yang, Hai-Chen; Liu, Tie-Bang; Rong, Han; Bi, Jian-Qiang; Ji, Er-Ni; Peng, Hong-Jun; Wang, Xiao-Ping; Fang, Yi-Ru; Yuan, Cheng-Mei; Si, Tian-Mei; Lu, Zheng; Hu, Jian; Chen, Zhi-Yu; Huang, Yi; Sun, Jing; Li, Hui-Chun; Hu, Chen; Zhang, Jin-Bei; Li, Ling-Jiang // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Background: The aim of this study was to test the ability of the Chinese version of the Mood Disorder Questionnaire (MDQ) to identify Bipolar Disorders (BD) in patients diagnosed with Major Depressive Disorder (MDD) or Unipolar Disorder (UD) in the clinical setting. Methods: 1,487 being treated...

  • A survey of the clinical acceptability of screening for postnatal depression in depressed and non-depressed women. Gemmill, Alan W.; Leigh, Bronwyn; Ericksen, Jennifer; Milgrom, Jeannette // BMC Public Health;2006, Vol. 6 Issue 1, p211 

    Background: Information on clinical acceptability is needed when making cost-utility decisions about health screening implementation. Despite being in use for two decades, most data on the clinical acceptability of the Edinburgh Postnatal Depression Scale (EPDS) come from qualitative reports, or...

  • Measures of Depressive Mood at Monthly Intervals. Little, J. Crawford; McPhail, Neil I. // British Journal of Psychiatry;Apr73, Vol. 122 Issue 569, p447 

    The article presents a study which measures the depressive moods of the same group of patients at monthly intervals. Two depression rating scales including R. C. B. Aitken's Visual Analogue Scale (VAS) and The Beck Depression Inventory (BDI) are carried out. In the study, eight female...

  • Influence of sub-syndromal symptoms after remission from manic or mixed episodes. Tohen, Mauricio; Bowden, Charles L.; Calabrese, Joseph R.; Lin, Daniel; Forrester, Tammy D.; Sachs, Gary S.; Koukopoulos, Athanasios; Yatham, Lakshmi; Grunze, Heinz // British Journal of Psychiatry;Dec2006, Vol. 189, p515 

    Background: Sub-syndromal symptoms in bipolar disorder impair functioning and diminish quality of life.Aims: To examine factors associated with time spent with sub-syndromal symptoms and to characterise how these symptoms influence outcomes.Method: In a...

  • Marital Problems and Treatment Outcome in Depressed Women: A Clinical Trial of Social Work Intervention. Corney, Roslyn H. // British Journal of Psychiatry;Nov87, Vol. 151, p652 

    In a clinical trial investigating the effectiveness of social work intervention with depressed women patients in general practice, 80 women were randomly allocated to an experimental group for referral to attached social workers or to a control group for routine treatment by their GPs. They were...

  • Depression screenings: Developing a model for use in a community pharmacy. Hare, Sarah Kerner; Kraenow, Kimberly // Journal of the American Pharmacists Association: JAPhA;Jan/Feb2008, Vol. 48 Issue 1, p46 

    Objective:To develop a depression screening model that can be replicated by other community pharmacists, conduct a depression screening in a community pharmacy, identify and appropriately refer patients with symptoms consistent with depression. Design: Uncontrolled study. Setting: Four...

  • CORRECTION.  // CMAJ: Canadian Medical Association Journal;9/3/2013, Vol. 185 Issue 12, p1067 

    A correction is presented to the clinical practice guidelines on screening for depression in adults, published in the June 11, 2013 print issue.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics